Cleared Traditional

K780909 - SYSMEX AUTO. BLOOD CELL COUNTER

K780909 is the FDA 510(k) clearance for SYSMEX AUTO. BLOOD CELL COUNTER by Toa Medical Electronics USA, Inc.. It is a Class 2 Hematology device (product code GKL) cleared through the Traditional 510(k) pathway after a 27-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1978
Decision
27d
Days
Class 2
Risk

K780909 is an FDA 510(k) clearance for the SYSMEX AUTO. BLOOD CELL COUNTER, CC-120. Classified as Counter, Cell, Automated (particle Counter) (product code GKL), Class II - Special Controls.

Submitted by Toa Medical Electronics USA, Inc. (Mchenry, US). The FDA issued a Cleared decision on June 28, 1978 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5200 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Toa Medical Electronics USA, Inc. devices

Submission Details

510(k) Number K780909 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 01, 1978
Decision Date June 28, 1978
Days to Decision 27 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
86d faster than avg
Panel avg: 113d · This submission: 27d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GKL Counter, Cell, Automated (particle Counter)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKL Counter, Cell, Automated (particle Counter)

All 53
Devices cleared under the same product code (GKL) and FDA review panel - the closest regulatory comparables to K780909.
COULTER COUNTER MODEL S PLUS
K792537 · Coulter Electronics, Inc. · Jan 1980
COULTER COUNTER-BLOOD CELL COUNTER
K792668 · Coulter Electronics, Inc. · Jan 1980
HEMO-W SYSTEM
K781628 · Coulter Electronics, Inc. · Oct 1978
COUNTER MODEL S PLUS BLOOD CELL COUNTER
K771512 · Coulter Electronics, Inc. · Nov 1977
AUTO. LEUCOCYTE DIFFER. ANALYZER D/90
K771728 · Technicon Instruments Corp. · Nov 1977
DETECTOTERGE AZIDE FREE
K771790 · J.T. Baker Chemical Co. · Oct 1977